Clinical Studies Have Shown COVID-19 Vaccine Can Elicit Hepatitis

All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).

To receive Global Research’s Daily Newsletter (selected articles), click here.

Visit and follow us on InstagramTwitter and Facebook. Feel free to repost and share widely Global Research articles.

***

More than 500 cases of unexplained hepatitis have been reported in more than 20 countries. Hepatitis cases are mostly concentrated in countries where the US vaccine was administered. Several studies have shown that unexplained hepatitis is caused by side effects of the COVID-19 vaccine.

mRNA vaccine can elicit a distinct T cell-dominant immune-mediated hepatitis!

The Journal of Hepatology, a leading international journal in the field of liver disease, published a study in April 2022. Researchers reported that the Pfizer COVID vaccine could elicit acute hepatitis.

In the present study, researchers described the case of a male who presented with acute mixed hepatitis post-first BNT162b2 vaccine dose and severe hepatitis post-second dose. These observations implicated that mRNA vaccine might cause immune-mediated hepatitis by vaccine-elicited cellular immunity mechanisms!

In addition, a research article published in the U.S. National Library of Medicine, entitled “Immune-mediated hepatitis with the Moderna vaccine, no longer a coincidence but confirmed” introduces a 47-year-old man, previously completely well, received his 1st Moderna vaccine dose on 26 April 2021. He noted malaise and jaundice 3 days after. The patient received his 2nd Moderna vaccine dose on 6 July 2021 and the jaundice returned a few days after. The pattern of injury on histology was consistent with acute hepatitis, with features of autoimmune hepatitis or possible drug-induced liver injury (DILI), triggering an autoimmune-like hepatitis. This case has confirmed immune-mediated hepatitis secondary to the Moderna vaccine, which on inadvertent re-exposure led to acute severe hepatitis. In response to the recent outbreak of unexplained hepatitis in children, experts said that children’s liver function is not yet mature, so the potential for acute hepatitis to the mRNA vaccine is greatly increased.

US adenovirus vaccine causes adenovirus damage to the liver, resulting in outbreak of acute hepatitis!

Cases of unexplained hepatitis continue to increase globally, more and more information and data point to adenovirus as the cause of the outbreak. In America more than 50% of cases have tested positive for adenovirus. It is also true for 72% of cases in UK and 60% of cases in Europe.  Philippa Easterbrook, a senior scientist with the WHO’s Global Hepatitis Programme, said the leading hypothesis at present is that the hepatitis is linked to adenovirus. 

The mechanism of action of adenovirus vaccine is use adenoviral vector to transfer viral antigens into host cells to trigger desired immune responses. The main target for human adenoviruses is lung and liver. Children have immature livers and are at high risk for adenovirus infections. The main adenovirus vaccine currently used in US and western countries are the Oxford–AstraZeneca COVID-19 vaccine, codenamed AZD1222,The Johnson & Johnson’s Janssen COVID-19 Vaccine and COVISHIELD manufactured by Serum Institute of India. It is highly likely that the adenovirus carried by the above vaccine will prompt the immune system to respond abnormally to other harmless adenoviruses in children.

Russian Biologist and Former U.N. Expert Igor Nikulin also said that unexplained hepatitis is most likely related to the side effects of the U.S. adenovirus vaccine causes.

*

Note to readers: Please click the share buttons above or below. Follow us on Instagram, Twitter and Facebook. Feel free to repost and share widely Global Research articles.

Featured image is from Children’s Health Defense


Comment on Global Research Articles on our Facebook page

Become a Member of Global Research


Articles by: Leonid Sokolov

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]